中国当代儿科杂志2018，Vol.20Issue(1)：67-71,5.DOI:10.7499/j.issn.1008-8830.2018.01.014
早产儿支气管肺发育不良的药物治疗研究进展
Research progress in drug therapy for bronchopulmonary dysplasia in preterm infants
杨雨晨1
作者信息
- 1. 中国医科大学附属盛京医院新生儿内科,辽宁 沈阳 110004
- 折叠
摘要
Abstract
Bronchopulmonary dysplasia (BPD) is the most common long-term complication in surviving extremely preterm infants. This may lead to pulmonary hypertension, increase late neonatal mortality, and cause abnormal neural development. There is still controversy over the efficacy, as well as advantages and disadvantages, of drug therapy for BPD in preterm infants. This article reviews the research progress in the drug therapy for BPD.关键词
支气管肺发育不良/药物治疗/早产儿Key words
Bronchopulmonary dysplasia/Drug therapy/Preterm infant引用本文复制引用
杨雨晨..早产儿支气管肺发育不良的药物治疗研究进展[J].中国当代儿科杂志,2018,20(1):67-71,5.
